無錫(xi)福祈(qi)制藥有限公(gong)(gong)司，前身為無錫(xi)市第二制藥廠，為江蘇(su)省(sheng)高新技(ji)術企(qi)業和江蘇(su)省(sheng)科技(ji)創新型企(qi)業, 始(shi)建(jian)于1943年，位于風景(jing)秀美的(de)太湖之濱。公(gong)(gong)司注冊資本32000萬元(yuan)人民幣，占地面積100,000平方米。公(gong)(gong)司主要(yao)生產抗生素原料(liao)藥、化學合成原料(liao)藥以及口服固體(ti)制劑；發酵(jiao)總量近500立方米，建(jian)有8個符(fu)合國(guo)內國(guo)際(ji)GMP要(yao)求的(de)生產車間。
無錫福祈制藥有限公(gong)司(si)(si)秉承“祈康(kang)厚生，福澤(ze)民眾”的信(xin)念宗旨(zhi)，致力于原料藥和成(cheng)品藥研(yan)發和生產(chan)，為(wei)客戶(hu)提供(gong)更好(hao)的產(chan)品與服務(wu)。公(gong)司(si)(si)質量(liang)管(guan)理體(ti)系(xi)完善，設備(bei)儀器先進，產(chan)品質量(liang)優良，配套設施完善。公司通過了由國內外藥品監督(du)管理機(ji)關組織中(zhong)囯GMP（2010）及歐洲GMP認證(zheng)(zheng)(zheng)，通過了清潔生產(chan)審核以(yi)及中(zhong)經科(ke)環(huan)基于GB/T24001-2016 idt ISO14001：2015 標準的環(huan)境(jing)管理體(ti)系認證(zheng)(zheng)(zheng)；GB/T45001-2020 idt ISO45001：2018 標準的職業(ye)健康安全管理體(ti)系認證(zheng)(zheng)(zheng)。
公司(si)擁有一大批高技術專業人(ren)士組成的人(ren)才隊(dui)伍，從事著(zhu)管理、科(ke)研(yan)、開(kai)發、生(sheng)產、營銷工作。
企業目前主要產品(pin)有硫酸(suan)奈替(ti)米(mi)星，硫酸(suan)西(xi)索米(mi)星，硫酸(suan)核糖霉素及螺旋霉素等(deng)抗生素藥(yao)物，嗎替(ti)麥(mai)考酚酯，他克莫司(si)等(deng)器(qi)(qi)官(guan)移(yi)植抗排斥方(fang)面的(de)藥(yao)物，產品(pin)遠銷歐(ou)洲(zhou)，美洲(zhou)，非洲(zhou)，及東南亞等(deng)幾十個國家和(he)地區。得(de)天獨厚(hou)的(de)先天優勢(shi)，造就(jiu)了企業深厚(hou)的(de)文(wen)化(hua)底(di)蘊；雄厚(hou)的(de)科學(xue)技術力量(liang)，為(wei)企業的(de)長足(zu)發(fa)展(zhan)(zhan)創造了機遇。在以(yi)質量(liang)求生存，以(yi)創新謀發(fa)展(zhan)(zhan)的(de)經營理念的(de)指(zhi)導下，無錫福(fu)祈積極開發(fa)治療(liao)器(qi)(qi)官(guan)移(yi)植抗排斥藥(yao)，新型抗腫瘤(liu)藥(yao)以(yi)及保肝藥(yao)等(deng)一系列(lie)的(de)新產品(pin)，并逐漸穩(wen)步拓展(zhan)(zhan)成品(pin)藥(yao)市場，為(wei)企業中長期的(de)發(fa)展(zhan)(zhan)提(ti)供持(chi)久動力。
強大的(de)(de)研發實力，堅實的(de)(de)生產技術，先進的(de)(de)管(guan)理(li)理(li)念，創新的(de)(de)經營思路和不斷自(zi)我提升的(de)(de)質量(liang)管(guan)理(li)體系是無(wu)錫福祈的(de)(de)競爭(zheng)優勢，企(qi)業正努力把(ba)自(zi)身建設成為國(guo)內外知名的(de)(de)現代化制藥企(qi)業。
WuxiFortune Pharmaceutical co., LTD is formerly known as Wuxi No. 2 Pharmaceutical Factory, is an new high-tech enterprise and technological innovation-based enterprise in Jiangsu Province. It was established in 1943 and located nearby the beautiful Taihu Lake. The registered capital is 320,000,000 RMB, and the total area is 100,000 m2. The main products are antibiotic APIs, chemical synthesis APIs and oral solid preparations. The total fermentation amount is about 500m3. There are eight workshops complied with the requirements of Current Chinese GMP (2010 version), which is equal to that of EU GMP, WHO GMP and ICH Q7A.
Wuxi Fortune pharmaceutical Co., LTD., adheres to the belief of "pray for the health, improve the living condition, bless the people", devotes to developing and manufacturing API and finished products, and provide better products and services. We have complete quality assurance system, advanced facility, providing good products, and perfect matching facilities. The company has passed the Chinese GMP (2010) Certification and European GMP Certification conducted by domestic and foreign regulatory administration authorities, cleaning production audit, the Environmental Management System Certification (GB/T24001-2016/ISO ISO14001:2015), and the Occupational Health and Safety Management System Certification (GB/T45001-2020/ISO 45001:2018) conducted by Beijing Zhongjing Quality Certification Co., Ltd.
At present, the main products are antibiotics drugs such as Netilmicin Sulfate, Sisomicin Sulfate, Ribostamycin Sulfate, and Spiramycin etc. and immunosuppressant like Mycophenolate Mofetiland Tacrolimus. Most of our products are exported to Europe, America, Africa, and Southeast Asia.
The advantagedsuperiority creates deep enterprise culture and the abundant science and technology strength create the development opportunities. Now Wuxi Fortune develops on the organ transplantation anti-rejection drugs, new antineoplastic and hepatoprotective. We also gradually expand the market of finished drug products to provide enduring power for the enterprise development. Strong research and development strength, firm production technology, advanced management ideas, innovative business ideas and continuous self-improvement quality management system are our competitive advantage. We work hard to make the enterprise become a famous modern pharmaceutical enterprise.
